Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Collegium Pharmaceutical Inc
COLL | US
32.50
USD0.22
0.68%
COLL | US
Loading StockChartView...
About Collegium Pharmaceutical Inc
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
24/04/2026
Close
32.50
Open
32.50
High
32.60
Low
31.87
Collegium Pharmaceutical Inc. a specialty pharmaceutical company develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER an abuse-deterrent and oral formulation of oxycodone for the management of pain severe enough to require daily around-the-clock long-term opioid treatment; Nucynta ER and Nucynta IR which are extended-release and immediate-release formulations of tapentadol; Belbuca a buccal film that contains buprenorphine; and Symproic an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals Inc. and changed its name to Collegium Pharmaceutical Inc. in October 2003. Collegium Pharmaceutical Inc. was incorporated in 2002 and is headquartered in Stoughton Massachusetts.
View LessCOLL | US
Risk
39.8
Sharpe
0.53
Luna's Score
39/100
Recommendation
Sell
Luna says (COLL | US)
What's Working
Strong Operating Margin (> 25%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
39.3%1 month
39.8%3 months
37.5%6 months
41.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
14.45
Fwd. PE
5.81
Price to book
5.79
Debt to equity
2.58
Debt to assets
0.53
Ent. to EBITDA
4.31
Ent. to rev.
2.67
PEG
-
Other Fundamentals
EBITDA
347.36M
MarketCap
1.05B
MarketCap(USD)
1.05B
Div. yield
-
Op. margin
32.68
Erngs. growth
52.30
Rev. growth
7.20
Ret. on equity
47.87
Short ratio
16.06
Short perc.
22.85
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.40
Range1M
4.73
Range3M
17.77
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.71
Price X volume
12.13M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 4.31 | 24.85 | Cheaper |
| Ent. to Revenue | 2.67 | 361.91 | Cheaper |
| PE Ratio | 14.45 | 30.05 | Cheaper |
| Price to Book | 5.79 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 37.48 | 65.24 | Lower Risk |
| Debt to Equity | 2.58 | -1.88 | Expensive |
| Debt to Assets | 0.53 | 0.48 | Par |
| Market Cap | 1.05B | 3.71B | Emerging |
